Archives

Beyond the Numbers: TMS Depression Outcomes Registry

The NeuroStar® Advanced Therapy depression outcomes registry was recently announced with 500+ patients, and 62% of patients experienced significant improvement in their depression symptoms. Why is this important? FDA-cleared in 2008, TMS uses MRI-strength magnetic field pulses to treat depression in patients who have not benefited from prior antidepressant medication. The registry is a way… Read More

NeuroStar® Advanced Therapy Depression Outcomes Registry Surpasses 500 Patient Milestone

Preliminary results validate real-world outcomes and continue to demonstrate TMS therapy is an important non-medication treatment option for depression MALVERN, Pa., May 22, 2017 /PRNewswire/ — NeuroStar® Advanced Therapy, the established leader in transcranial magnetic stimulation (TMS), today announced its depression outcomes registry has exceeded 500 patients at approximately 50 treatment facilities in the United… Read More